Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Alopecia areata patients have higher risks of infections, lymphoma, heart issues, and death.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Pneumatic compression can cause skin bruising even in healthy individuals.

Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

CTP-543 is generally safe for treating alopecia areata.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

JAK inhibitors show promise for treating various skin diseases.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The patient recovered well and returned to college without any lasting issues.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.